News

Press Releases

Position Papers

AIM Flash

AIM Briefing

On 2 December, Dr. Thomas Ulmer (MEP (Germany, EPP) and Carl Schlyter MEP (Sweden, Greens), hosted and chaired an expert meeting on the European Commissions controversial legislative proposals on 'information' to the general public on prescription medicines. More than 90 participants attended, representing the full spectrum of healthcare stakeholders. The press release and presentations are available here.

Presentations and press release EN , FR 

Good practices on relevant health information for patients and consumers

• Introduction by the Chair, Thomas Ulmer MEP
  
• Direct to Consumer “Information” by the pharmaceutical industry - a déjà vu? by Dr Barbara Mintzes, Assistant Professor at University of British Columbia (Canada)
  
• What is the added value of the directive on information to the general public on medicinal products subject to medical prescription?
  Responses from:
• Ilaria Passarani, Head of Health Department at European Consumers’ Organisation (BEUC), Powerpoint presentation
• Jörg Schaaber, President of the International Society of Drug Bulletins (ISDB), Powerpoint presentation
• Access to information – Patients’ and citizens demands
  Interventions from:
• Cédric Diat, from the Association François Aupetit (Crohn’s disease) (AFA), Powerpoint presentation
• Anne-Sophie Parent, AGE - European Older People’s Platform, Powerpoint presentation
  
• Open Discussion
  
• Conclusion by the Chair, Carl Schlyter MEP